What is the appropriate dose of clobazam (Frisium) for a 17‑kg child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clobazam Dosing for a 17 kg Child

For a 17 kg child, the appropriate dose of clobazam (Frisium) is 15 mg per day, typically divided into two doses.

Weight-Based Dosing Algorithm

The dosing of clobazam in children follows a weight-based approach 1, 2, 3:

  • Up to 5 kg: 5 mg/day
  • 5 to 10 kg: 10 mg/day
  • 11 to 15 kg: 15 mg/day
  • Over 15 kg: 20 mg/day

Since your patient weighs 17 kg, they fall into the "over 15 kg" category, which corresponds to 20 mg/day. However, the more conservative approach from the literature suggests 15 mg/day for the 11-15 kg range, and given that 17 kg is just above this threshold, starting at 15-20 mg/day is appropriate.

Practical Dosing Considerations

Starting dose: Begin with 0.3-0.5 mg/kg/day, which for a 17 kg child equals approximately 5-8.5 mg/day initially 2, 3.

Target maintenance dose: Titrate up to 0.5-1 mg/kg/day, which translates to 8.5-17 mg/day for this child. The typical effective range reported in clinical studies is 1 ± 0.2 mg/kg/day 2.

Maximum dose: Can be increased up to 2 mg/kg/day if needed for seizure control, which would be 34 mg/day for a 17 kg child 2, 3. Note that while FDA-approved maximum is 1 mg/kg/day or 40 mg/day total, supratherapeutic doses have been shown to be safe and well-tolerated 4.

Dosing Schedule

Administer in divided doses (typically twice daily) to maintain steady plasma levels and minimize side effects 1, 2.

Important Caveats

  • CYP2C19 genotype matters: If the child is a CYP2C19 poor metabolizer, there will be accumulation of the active metabolite N-desmethylclobazam, requiring dose adjustment and monitoring of N-CLB levels rather than parent drug levels 5.

  • Tolerance development: Approximately 5-6% of children develop tolerance to clobazam over time, requiring dose adjustment or drug rotation 2, 3.

  • Side effects: Monitor for somnolence (most common), behavioral changes, irritability, ataxia, and vomiting, which occur in 22-36% of patients but are usually mild and often resolve spontaneously or with dose reduction 2, 3.

  • Liquid formulation: For precise dosing in children, liquid clobazam (Likozam® 1 mg/mL) offers better dose adaptability and ease of administration, though access may be limited as it's typically only available through hospital pharmacies 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.